Chemiluminescence test kit PATHFAST™ Myoglobin
mass

Chemiluminescence test kit - PATHFAST™ Myoglobin - PHC Europe B.V. / PHCbi - mass
Chemiluminescence test kit - PATHFAST™ Myoglobin - PHC Europe B.V. / PHCbi - mass
Chemiluminescence test kit - PATHFAST™ Myoglobin - PHC Europe B.V. / PHCbi - mass - image - 2
Chemiluminescence test kit - PATHFAST™ Myoglobin - PHC Europe B.V. / PHCbi - mass - image - 3
Chemiluminescence test kit - PATHFAST™ Myoglobin - PHC Europe B.V. / PHCbi - mass - image - 4
Chemiluminescence test kit - PATHFAST™ Myoglobin - PHC Europe B.V. / PHCbi - mass - image - 5
Add to favorites
Compare this product
 

Characteristics

Technology
chemiluminescence, mass

Description

PATHFAST™ determines the quantity of hs Trop I, NTproBNP, D-Dimer, hsCRP, Myoglobin and CK-MB mass from one single whole blood sample. The quantitative data of the parallel analyses provide results within minutes, which facilitate the therapeutical decision. Basis for a safe diagnosis on-site for patients with acute coronary syndrome, suspected coronary heart insufficiency, venous thromboembolism, inflammation and myocardial injury . PATHFAST™ hs-cTnI is an immunoassay for the in vitro quantitative determination of cardiac Troponin I (cTnI) in human anticoagulated whole blood and plasma on the PATHFAST™ analyzer. PATHFAST™ hs-cTnI can be used as an aid in the diagnosis of acute myocardial infarction and in the risk stratification of patients presenting with acute coronary syndromes. In addition to the diagnosis of AMI, detection of low cardiac troponin levels may make it possible to predict information (risk stratification) in terms of short- and long term mortality of patients. Low concentrations of cTnI can be analysed by using high sensitivity cardiac troponin (hs-cTnI) assays which meet the criteria defined by IFCC and ESC. PATHFAST™ provides high accuracy and precision of test results similar to central lab analyser, combined with the flexibility of a POCT assay below 17 minutes out of whole blood and plasma by all in one cartridge solution. The new PATHFAST™ hs-cTnI assay fits for the recommen[1]dations on the IFCC and ESC guidelines for the early detection of AMI.

Catalogs

No catalogs are available for this product.

See all of PHC Europe B.V. / PHCbi‘s catalogs
*Prices are pre-tax. They exclude delivery charges and customs duties and do not include additional charges for installation or activation options. Prices are indicative only and may vary by country, with changes to the cost of raw materials and exchange rates.